• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchHilleVax
    Picture of HilleVax logo

    HLVX — HilleVax News Story

    $2.090.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapNeutral
    • Market Cap
      $104.79m
    • Enterprise Value
      -$54.75m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • HLVX Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    HLVX Dividends
    All News

    NASDAQ RESUMED AT 11:49 AM

    Picture of HilleVax logoHilleVax
    29/04/2022 16:49
    NASDAQ RESUMED  HLVX.O  AT 11:49 AM
    

    Recent news on HilleVax

    See all news
    • Brief: XOMA Royalty Announces Closing Of Tender Offer For HilleVax

      17/09/2025 14:01
    • Brief: Hillevax Enters Into A Definitive Agreement To Be Acquired By Xoma Royalty For $1.95 In Cash Per Share Plus A Contingent Value Right

      04/08/2025 14:04
    • U.S. STOCKS ON THE MOVE-US energy sector, Oshkosh, Meta

      06/12/2024 18:45
    • U.S. STOCKS ON THE MOVE-Zumiez, BTC Digital, WesBanco

      06/12/2024 15:52
    • U.S. STOCKS ON THE MOVE-Petco Health, Smith & Wesson, Victoria's Secret

      06/12/2024 14:16

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.